Basic Information
ID: ALA3806729
Type: ADME
Description: Drug level in human hepatocytes assessed as aldehyde oxidase-mediated compound formation treated with (S)-4-Amino-6-((1-(5-chloro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile at 1 uM by LC/MS/MS analysis
Format: BAO_0000219
Organism: Homo sapiens
Cell type: Hepatocyte
Target: Aldehyde oxidase(ALA3257)
Document: ALA3804828
Drug level in human hepatocytes assessed as aldehyde oxidase-mediated compound formation treated with (S)-4-Amino-6-((1-(5-chloro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile at 1 uM by LC/MS/MS analysis: 1
Activity Charts
Bioactivity
Activity Types for Assay ALA3806729
Drug metabolism
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 433.86 | 3.16 | 3.16 |